Core Laboratories (CLB) Stock Price, News & Analysis

Company Overview

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Key Stats

• Today's Range: $12.39 to $12.78
• 50-Day Range: $10.62 to $12.71
• 52-Week Range: $10.14 to $25.13
• Volume: 822,040 shs
• Average Volume: 406,005 shs
• Market Capitalization: $582.39 million
• P/E Ratio: 21.06
• Dividend Yield: 0.32%
• Price Target: $15.00
• Consensus Rating: Reduce

Core Laboratories Stock Analysis - MarketRank™

Core Laboratories scored higher than 52% of companies evaluated by MarketBeat, and ranked 469th out of 807 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Core Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on no buy ratings, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Core Laboratories has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 15.63%

Earnings Growth

Earnings for Core Laboratories are expected to grow by 15.63% in the coming year, from $0.96 to $1.11 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Core Laboratories is 21.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54.

Price to Earnings Ratio vs. Sector

The P/E ratio of Core Laboratories is 21.06, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 54.67.

Price to Earnings Growth Ratio

Core Laboratories has a PEG Ratio of 3.87. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Core Laboratories has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

22.34% of the float of Core Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Core Laboratories has a short interest ratio ("days to cover") of 15.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Core Laboratories has recently decreased by 3.08%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Core Laboratories has a dividend yield of 0.32%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Core Laboratories does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Core Laboratories is 6.78%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.60% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

22.34% of the float of Core Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Core Laboratories has a short interest ratio ("days to cover") of 15.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Core Laboratories has recently decreased by 3.08%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.05

News Sentiment

Core Laboratories has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Energy companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Core Laboratories this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for CLB on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Core Laboratories insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.94% of the stock of Core Laboratories is held by insiders.

Percentage Held by Institutions

97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CLB Stock Analysis - Frequently Asked Questions

How have CLB shares performed this year?

Core Laboratories' stock was trading at $17.31 at the start of the year. Since then, CLB shares have decreased by 28.2% and is now trading at $12.4230.
View the best growth stocks for 2025 here.

How were Core Laboratories' earnings last quarter?

Core Laboratories Inc. (NYSE:CLB) announced its earnings results on Wednesday, April, 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by $0.01. The firm's revenue for the quarter was down 4.7% compared to the same quarter last year.
Read the conference call transcript.

Who are Core Laboratories' major shareholders?

Top institutional shareholders of Core Laboratories include Ariel Investments LLC (22.06%), Vanguard Group Inc. (11.55%), Earnest Partners LLC (7.74%) and T. Rowe Price Investment Management Inc. (2.34%).
View institutional ownership trends.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 4/23/2025
• Record date for 5/27 Dividend: 5/05/2025
• Ex-Dividend for 5/27 Dividend: 5/05/2025
• Dividend Payable: 5/27/2025
• Today: 6/21/2025
• Next Earnings (Estimated): 7/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Energy
• Industry: OIL - FIELD SVCS
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: NYSE:CLB
• CIK: 1000229
• Web: www.corelab.com
• Phone: (713) 328-2673
• Fax: N/A
• Employees: 3,500
• Year Founded: 1936

Price Target and Rating

• Average Stock Price Target: $15.00
• High Stock Price Target: $17.00
• Low Stock Price Target: $13.00
• Potential Upside/Downside: +20.7%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.59
• Trailing P/E Ratio: 21.06
• Forward P/E Ratio: 12.94
• P/E Growth: 3.87
• Net Income: $31.40 million
• Net Margins: 5.41%
• Pretax Margin: 8.28%
• Return on Equity: 15.06%
• Return on Assets: 6.45%

Debt

• Debt-to-Equity Ratio: 0.48
• Current Ratio: 2.21
• Quick Ratio: 1.64

Sales & Book Value

• Annual Sales: $523.85 million
• Price / Sales: 1.11
• Cash Flow: $1.17 per share
• Price / Cash Flow: 10.66
• Book Value: $5.49 per share
• Price / Book: 2.26

Miscellaneous

• Outstanding Shares: 46,880,000
• Free Float: 46,442,000
• Market Cap: $582.39 million
• Optionable: Optionable
• Beta: 1.40